Photocrosslinkable poly (caprolactone fumarate)
Fumaric acid or a salt thereof, such as a fumaryl halide (e.g. fumaryl chloride), which contains unsaturated carbon-carbon double bonds that can be used for in situ crosslinking, is copolymerized with poly(caprolactone)diol in the presence of an alkali metal salt. The resulting photocrosslinkable biocompatible and bioresorbable poly(caprolactone fumarate) biomaterial is useful in the fabrication of injectable an in-situ hardening scaffolds for application in skeletal reconstruction.
1. A scaffold for tissue regeneration, the scaffold comprising:
a biodegradable matrix comprising a copolymer including caprolactone units and fumarate;
wherein the copolymer is photocrosslinkable, colorless or light colored, and clear in the melt state;
wherein the matrix includes particulate or fiber reinforcement materials and a bioactive agent selected from enzymes, organic catalysts, ribozvmes, organometallics, proteins, glycoproteins, peptides, polyamino acids. Antibodies, nucleic acids, steroidal molecules, antibiotics, antimycotics, cvtokines, growth factors, carbohydrates, oleophobics, lipids, extracellular matrix and/or its individual components, pharmaceuticals, therapeutics and mixtures thereof.
2. The scaffold of claim 1 wherein:
reinforcement materials comprise hydroxyapatite.
3. The scaffold of claim 1 wherein:
the scaffold is porous.
4. A method of making a scaffold, the method comprising:
preparing a copolymer by reacting (i) a poly(ε-caprolactone)diol and (ii) fumaric acid or a salt thereof in the presence of potassium carbonate to form a repeating polymer of polycaprolactone fumarate wherein the copolymer is photocrosslinkable, colorless or light colored, and clear in the melt state;
forming a biodegradable matrix of the copolymer;
adding a particulate or fiber reinforcement materials to the matrix; and
forming a scaffold of the matrix using a method selected from the group consisting of: extrusion, injection molding, compression molding and a solid free-form fabrication method.
5. The method of claim 4 further comprising:
adding to the matrix a bioactive agent selected from enzymes, organic catalysts, ribozymes, organometallics, proteins, glycoproteins, peptides, polyamino acids, antibodies, nucleic acids, steroidal molecules, antibiotics, antimycotics, cytokines, growth factors, carbohydrates, oleophobics, lipids, extracellular matrix and/or its individual components, pharmaceuticals, therapeutics and mixtures thereof.
6. The scaffold of claim 4 wherein the solid free-form fabrication method is selected from the group consisting of stereo-lithography, selective laser sintering, ballistic particle manufacturing, fusion deposition modeling, and three dimensional printing.
7. The scaffold of claim 1 , wherein the copolymer is prepared by reacting (i) a poly(ε-caprolactone)diol and (ii) fumaric acid or a salt thereof in the presence of potassium carbonate to form a repeating polymer of polycaprolactone fumarate.
8. The scaffold of claim 1 , wherein the scaffold is formed using a method selected from the group consisting of: extrusion, injection molding, compression molding and a solid free-form fabrication method.
9. The scaffold of claim 1 , wherein the copolymer is colorless.
10. The method of claim 4 , wherein the copolymer is colorless.
11. The scaffold of claim 8 , wherein the solid free-form fabrication method is selected from the group consisting of stereo-lithography, selective laser sintering, ballistic particle manufacturing, fusion deposition modeling, and three dimensional printing.
12. The scaffold of claim 7 , wherein:
the copolymer is prepared by reacting (i) a poly(ε-caprolactone)diol and (ii) a fumaryl halide.
13. The scaffold of claim 7 , wherein:
the copolymer is prepared by reacting (i) a poly(ε-caprolactone)diol and (ii) fumaryl chloride.